WNT6 and glioma: We previously described that WNT6 expression increases with glioma grade (Gonçalves et al., 2018), but it was still unknown whether this is associated with IDH mutation and/or 1p/19q codeletion status—the two most critical diagnostic molecular factors used in the new 2016 WHO classification of glioma (Louis et al., 2016).